Suven Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Profit before tax

408.77

579.39

722.45

413.98

357.59

Net cashflow-operating activity

370.65

484.17

269.89

329.73

367.78

Net cash used in investing activity

-381.58

-235.57

-90.36

-257.66

-374.73

Netcash used in fin. activity

-13.78

-235.79

-156.41

-76.55

7.62

Net inc/dec in cash and equivlnt

-24.71

12.81

23.12

-4.48

-

Cash and equivalnt begin of year

43.02

30.21

7.09

11.58

-

Cash and equivalnt end of year

18.31

43.02

30.21

7.09

0.67